97-78-9

应用筛选条件

关键词:'97-78-9'

显示 1-10 #N/A 905 条结果关于 "97-78-9" 范围网站内容

Phosgene is 170 times more reactive than TP, the main phosgene substitute. Therefore, reactions with phosgene can be carried out under much milder conditions than with TP. Compounds will react faster and at lower temperatures (often at -78°C), preserving sensitive

X-tremeGENE™ 9 DNA Transfection Reagent Protocol

Plate cells approx. 24 hours before transfection making sure cells are at optimal concentration (70 – 90 % confluency).

CRISPR Cas 9 Nuclease RNA-guided Genome Editing

Learn about CRISPR Cas9, what it is and how it works. CRISPR is a new, affordable genome editing tool enabling access to genome editing for all.

Color Determination of sugar based on ICUMSA Color GS2-9

Learn about the ICUMSA® Method GS2-9 (2024) to measure the color of sample solutions of white sugar or highly pure sugar syrup of color index up to 600 IU.

X-tremeGENE™ 9 DNA转染试剂实验方案

约转染前24小时接种细胞，确保细胞处于最佳密度（7090 %融合度）。

元素周期表

下载可打印的元素周期表，包括元素名称、原子质量和原子序数，供快速参考和实验室使用。

LC/MS Analysis of Phospholipids in Milk on Asc

(soybean), ≥97%; L-α-Phosphatidylethanolamine from egg yolk, Type III, ≥97% (TLC), lyophilized powder; L-α-Phosphatidylcholine, from egg yolk, Type XVI-E, ≥99% (TLC), lyophilized powder; Sphingomyelin, from chicken egg yolk, ≥95%

Merck Expands in Gillingham, UK, Boosts Distribution Capabilities

Merck today announced the completion of a £9 million expansion to its Gillingham distribution center.

Accelerated mAb Development Program – From Transfection to GMP Drug Substance in 9 Months

The accelerated mAb development program delivers GMP drug substance nine months from transfection. We designed the mAbExpress™ program to be fast, cost effective, and appropriate for the early clinical phase of your program, with regulatory support throughout.

How to Boost AAV Titer with Feed Supplementation in both HEK293 and Sf-9 Platforms

In this webinar, you will learn wow to boost AAV titers in HEK293 and Sf-9 cell lines as well as getting some insider tips on volume and timing optimization.

1/91